Tumor-treating fields plus chemotherapy versus chemotherapy alone for (...)TTFields plus chemotherapy after first disease recurrence on TTFields plus temozolomide or temozolomide alone prolonged OS in patients in the EF-14 trial.·ncbi.nlm.nih.gov·Jun 5, 2021Tumor-treating fields plus chemotherapy versus chemotherapy alone for (...)
